z-logo
open-access-imgOpen Access
Long hidden sepsis subgroup may benefit from immune therapy
Author(s) -
Mark Tidswell
Publication year - 2018
Publication title -
journal of emergency and critical care medicine
Language(s) - English
Resource type - Journals
ISSN - 2521-3563
DOI - 10.21037/jeccm.2018.12.03
Subject(s) - sepsis , medicine , inflammation , intensive care medicine , innate immune system , immune system , clinical trial , systemic inflammatory response syndrome , immunology , mortality rate , bioinformatics , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here